FDA inspection
Eli Lilly & Company: FDA inspection ending Feb 14, 2013
FDA inspection 817823 · Voluntary Action Indicated (VAI) · Indianapolis, IN
Key facts
| Inspection ID | 817823 |
|---|---|
| Firm | Eli Lilly & Company |
| FEI number | 1819470 |
| Address | 1555 S Harding St |
| City | Indianapolis |
| State | IN |
| ZIP | 46285 |
| Country | United States |
| Fiscal year | 2013 |
| Inspection end date | Feb 14, 2013 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data